ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,399Medicare Part D Prescriptions Filled, Including Refills

Rank: 270 out of 1454

$575K Total Retail Price of All Prescriptions

Rank: 348 out of 1454

501 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 501 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 501 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 9,111 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 454 374 1 1
HYDROCODONE-ACETAMINOPHEN 453 305 S3 2 7
LEVOTHYROXINE SODIUM 438 392 3 5
AMLODIPINE BESYLATE 341 285 4 2
OMEPRAZOLE 325 242 5 3
LISINOPRIL 318 287 6 4
FUROSEMIDE 312 257 7 6
ZOLPIDEM TARTRATE 299 222 8 19
METFORMIN HCL 246 212 9 8
WARFARIN SODIUM 210 192 10 17
METOPROLOL TARTRATE 201 180 11 10
HYDROCHLOROTHIAZIDE 189 149 12 9
TRAMADOL HCL 165 119 13 20
PRAVASTATIN SODIUM 164 144 14 12
CITALOPRAM HBR 160 121 15 21
NEXIUM 157 119 16 23
TAMSULOSIN HCL 130 130 17 34
SYNTHROID 117 80 18 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 116 88 19 27
MELOXICAM 116 90 19 37
ATORVASTATIN CALCIUM 112 106 21 11
ENALAPRIL MALEATE 111 99 22 58
CLOPIDOGREL 110 95 23 32
GLIPIZIDE XL 109 107 24 85
DIOVAN 109 90 24 40
POTASSIUM CHLORIDE 106 97 26 15
GABAPENTIN 104 90 27 16
CARVEDILOL 101 89 28 24
METOPROLOL SUCCINATE 96 81 29 13
AZITHROMYCIN 87 57 30 42
LOSARTAN POTASSIUM 86 62 31 14
DILTIAZEM ER 81 81 32 126
OXYCODONE-ACETAMINOPHEN 78 52 S2 33 60
PROMETHAZINE HCL 78 51 R 33 82
ATENOLOL 77 73 35 18
DONEPEZIL HCL 73 73 36 29
FLUTICASONE PROPIONATE 72 48 37 30
ALLOPURINOL 70 55 38 28
DIGOXIN 70 70 38 70
CYCLOBENZAPRINE HCL 69 53 R 40 59
QUINAPRIL HCL 69 41 40 101
FENOFIBRATE 65 63 42 68
ZETIA 64 64 43 69
TRAZODONE HCL 64 55 43 50
PLAVIX 64 57 43 45
ALENDRONATE SODIUM 62 62 46 35
SERTRALINE HCL 62 46 46 26
GLIPIZIDE ER 60 49 48 92
PANTOPRAZOLE SODIUM 59 53 49 31
GLIMEPIRIDE 59 58 49 33
HYDROXYZINE HCL 58 57 R 51 183
LOVASTATIN 58 58 51 39
ESCITALOPRAM OXALATE 57 42 53 78
FLUOXETINE HCL 55 41 54 72
TRICOR 53 48 55 134
CLONIDINE HCL 52 27 56 49
CEFDINIR 52 37 56 182
PROAIR HFA 50 36 58 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.